Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Terazosin Hydrochloride Tablets

Approval Number

国药准字H20059992

Company苏州东瑞制药有限公司

Registration Date

August 17, 2020

Drug Information

Generic Name

盐酸特拉唑嗪片

Dosage Form

片剂

Strength

5mg(按C19H25N5O4·HCl计)

Drug Type

化学药品

Registration Date

August 17, 2020

Company Information

Applicant Company

Company Name苏州东瑞制药有限公司

Company Address

江苏省苏州吴中经济开发区民丰路268号

Manufacturing Company

Company Name苏州东瑞制药有限公司

Company Address

江苏省苏州吴中经济开发区民丰路268号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy